0000805928-21-000184.txt : 20211229 0000805928-21-000184.hdr.sgml : 20211229 20211229163101 ACCESSION NUMBER: 0000805928-21-000184 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211227 FILED AS OF DATE: 20211229 DATE AS OF CHANGE: 20211229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scopelianos Angelo CENTRAL INDEX KEY: 0001751541 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36046 FILM NUMBER: 211529199 MAIL ADDRESS: STREET 1: C/O AXOGEN, INC. STREET 2: 13631 PROGRESS BOULEVARD - SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axogen, Inc. CENTRAL INDEX KEY: 0000805928 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411301878 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: (386) 462-6817 MAIL ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 FORMER COMPANY: FORMER CONFORMED NAME: AxoGen, Inc. DATE OF NAME CHANGE: 20111004 FORMER COMPANY: FORMER CONFORMED NAME: LECTEC CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 wf-form4_164081344903243.xml FORM 4 X0306 4 2021-12-27 0 0000805928 Axogen, Inc. AXGN 0001751541 Scopelianos Angelo 13631 PROGRESS BOULEVARD SUITE 400 ALACHUA FL 32615 0 1 0 0 Chief R&D Officer Common Stock 2021-12-27 4 M 0 1150 0 A 11270 D Common Stock 2021-12-27 4 F 0 286 9.74 D 10984 D Restricted Stock Units 2021-12-27 4 M 0 1150 0 D 2022-12-27 2022-12-27 Common Stock 2300.0 1150 D This reflects the number of restricted stock units that vested on December 27, 2021. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. /s/ Angelo Scopelianos 2021-12-29